This page shows the latest Microbiome news and features for those working in and with pharma, biotech and healthcare.
Drug reduced C.difficile infection recurrence. Seres Therapeutics has reported positive topline data from a phase 3 trail of its microbiome therapy SER-109 for recurrent C.difficile infections. ... SER-109 is an oral, biologically-derived microbiome
The Evotec and Daré deals sandwiched two other agreements signed in the last few days, including a partnership with Azitra to develop skin microbiome-based treatments for eczema, and another with
Finch’s pipeline includes CP101, an oral capsule that contains a diverse community of microbiota to restore a balanced microbiome. ... Prior studies have suggested the link between the two is a disrupted microbiome.
of Seres’ microbiome candidates – SER-401 – tested in combination with AZ’s cancer therapies including its PD-L1 checkpoint inhibitor Imfinzi (durvalumab). ... One of the targets of the AZ-backed project will be to see if the microbiome can serve
diff – along with other beneficial bacteria in the gut – they can be used to restore the balance of the bacterial colonies or ‘microbiome’ that naturally populate our bodies. ... Takeda bought into the programme in 2017, and is also partnering
damaging to the normal microbiome of the gastrointestinal tract. ... Preserving the microbiome makes it less likely that the pathogen can re-establish itself once treatment finishes, it suggests.
More from news
Approximately 7 fully matching, plus 10 partially matching documents found.
Takeda’s strategy is to develop GI products that address the highest unmet needs, which includes projects across three novel platforms – gene therapy, microbiome and cell therapy.
How is Microbiotica advancing life sciences with its technology? Microbiotica is a leading expert in the microbiome and is using its technology to identify the good and bad microbiomes in patients. ... There is also a $534m collaboration with Roche’s
If you need another example, look in the mirror and consider that a large part of the creature facing you is made of other organisms, such as those in your microbiome.
immuno-oncology collaboration based on Enterome's microbiome technology.
The human microbiome is an example of this but a coral reef is a better one.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
His experience and leadership in pioneering new drug modalities will be invaluable as we advance our pipeline of microbiome-modulating therapies.”. ... Dr Roberts said: “Microbiome modulation is among the most exciting and rapidly evolving fields in
Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.
Ritter is currently developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. ... microbiome. “I believe my experience in product development coupled with my research capabilities will be a great
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
This data will come from a patient’s genetics, electronic health records, microbiome, diet, lifestyle, and will be the driving force behind improved outcomes.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...